A Composite Assay for HER2-positive Early-stage Breast Cancer Management

NCT06762977 · clinicaltrials.gov ↗

RECRUITING

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer Early Stage Breast Cancer (Stage 1-3)
HER2

Sponsor

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Collaborators

[object Object]
[object Object]